A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma.

NCT05288504 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Eosinophilic Asthma

Interventions

DRUG: AVTX-002
DRUG: Placebo

Sponsor

Avalo Therapeutics, Inc.